Medicare Enrolled

Dr. Omid Saeed Tehrani, M.D., PH.D,

Hematology & Oncology · Fresno, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
2335 E KASHIAN LN, Fresno, CA 93701
5592569680
In practice since 2009 (16 years)
NPI: 1659508281 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Saeed Tehrani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Saeed Tehrani? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Saeed Tehrani

Dr. Omid Saeed Tehrani is a hematology & oncology specialist in Fresno, CA, with 16 years of NPI registration. Based on federal Medicare data, Dr. Saeed Tehrani performed 861 Medicare services across 315 unique beneficiaries.

Between the years covered by Open Payments, Dr. Saeed Tehrani received a total of $8,574 from 54 pharmaceutical and/or device companies across 239 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Saeed Tehrani is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice ▲ 861 Medicare services $8,574 industry payments

Medicare Practice Summary

Medicare Utilization ↗
861
Medicare services
Bottom 46% in CA for hematology & oncology
315
Unique beneficiaries
$131
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~54 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
620 $139 $250
New patient office visit, complex (60-74 min) 71 $163 $300
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
69 $95 $150
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
53 $138 $250
Annual depression screening 48 $19 $25
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,574
Total received (2018-2024)
Avg $1,429/year across 6 years
Top 34% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
239
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,604 (53.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,681 (42.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$289 (3.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,927
2023
$965
2022
$595
2021
$1,368
2019
$38
2018
$3,681

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$210
Novartis Pharmaceuticals Corporation
$193
Merck Sharp & Dohme LLC
$170
GlaxoSmithKline, LLC.
$87
Mirati Therapeutics, Inc.
$86
Genentech USA, Inc.
$73
Celgene Corporation
$73
Exelixis Inc.
$62
AstraZeneca Pharmaceuticals LP
$55
Eisai Inc.
$55
PharmaEssentia USA Corporation
$50
Astellas Pharma US Inc
$48
Daiichi Sankyo Inc.
$47
Lilly USA, LLC
$46
ADC Therapeutics America, Inc.
$44
TAIHO ONCOLOGY, INC.
$44
SOBI, INC
$41
Medtronic, Inc.
$41
Regeneron Healthcare Solutions, Inc.
$40
E.R. Squibb & Sons, L.L.C.
$36
PFIZER INC.
$35
Boehringer Ingelheim Pharmaceuticals, Inc.
$34
Gilead Sciences, Inc.
$33
Deciphera Pharmaceuticals Inc.
$32
Ipsen Biopharmaceuticals, Inc
$31
Tempus AI, Inc
$29
ABBVIE INC.
$29
PUMA BIOTECHNOLOGY, INC.
$28
Incyte Corporation
$26
Takeda Pharmaceuticals U.S.A., Inc.
$26
Stemline Therapeutics Inc.
$25
RECORDATI_RARE_DISEASES_INC.
$24
GENZYME CORPORATION
$21
SpringWorks Therapeutics, Inc.
$21
EMD Serono, Inc.
$17
Pharmacosmos Therapeutics Inc.
$16
Top 3 companies account for 29.8% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$3,837
Janssen Biotech, Inc.
$528
Novartis Pharmaceuticals Corporation
$348
E.R. Squibb & Sons, L.L.C.
$286
Celgene Corporation
$282
Merck Sharp & Dohme LLC
$236
AstraZeneca Pharmaceuticals LP
$207
Amgen Inc.
$192
Genentech USA, Inc.
$163
Mirati Therapeutics, Inc.
$161
Lilly USA, LLC
$155
Eisai Inc.
$133
GlaxoSmithKline, LLC.
$128
Astellas Pharma US Inc
$108
Gilead Sciences, Inc.
$105
Daiichi Sankyo Inc.
$103
SANOFI-AVENTIS U.S. LLC
$99
Exelixis Inc.
$99
Incyte Corporation
$88
Regeneron Healthcare Solutions, Inc.
$85
Merck Sharp & Dohme Corporation
$85
GENZYME CORPORATION
$69
SOBI, INC
$57
EMD Serono, Inc.
$55
Seagen Inc.
$55
Deciphera Pharmaceuticals Inc.
$54
Boehringer Ingelheim Pharmaceuticals, Inc.
$53
PharmaEssentia USA Corporation
$50
Stemline Therapeutics Inc.
$49
PUMA BIOTECHNOLOGY, INC.
$46
Sobi, Inc
$45
ADC Therapeutics America, Inc.
$44
TAIHO ONCOLOGY, INC.
$44
Medtronic, Inc.
$41
Karyopharm Therapeutics Inc.
$38
AbbVie Inc.
$38
MorphoSys, US Inc.
$38
ImmunoGen, Inc.
$37
Ipsen Biopharmaceuticals, Inc
$31
Tempus AI, Inc
$29
ABBVIE INC.
$29
EISAI INC.
$26
Takeda Pharmaceuticals U.S.A., Inc.
$26
RECORDATI_RARE_DISEASES_INC.
$24
SpringWorks Therapeutics, Inc.
$21
Taiho Oncology, Inc.
$21
BeiGene USA, Inc.
$20
Clovis Oncology, Inc.
$20
Tactile Systems Technology Inc
$18
CTI BioPharma Corp.
$17
Pharmacosmos Therapeutics Inc.
$16
Aveo Pharmaceuticals, Inc.
$16
ARRAY BIOPHARMA INC
$12
Dova Pharmaceuticals
$12
Top 3 companies account for 55.0% of all-time payments
Associated products mentioned in payments ›
BAVENCIO · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CYRAMZA · DARZALEX · DOPTELET · Doptelet · ELITEK · ENHERTU · ERLEADA · Elahere · Enhertu · FOTIVDA · Fabhalta · Flexitouch Plus · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INQOVI · JEMPERLI · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · NINLARO · OGSIVEO · ONUREG · OPDIVO · OPDUALAG · Onivyde · Orserdu · PADCEV · PLUVICTO · PROMACTA · Pomalyst · QINLOCK · REBLOZYL · SARCLISA · SCEMBLIX · SYLVANT · SYNCHROMEDII · TAGRISSO · TALVEY · TASIGNA · TECENTRIQ · TECVAYLI · TUKYSA · Tecentriq · Trodelvy · VENCLEXTA · VERZENIO · VONJO · VYNDAQEL · Venclexta · Vonjo · XPOVIO · XT CDX · XTANDI · Xospata · Xtandi · ZEJULA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (54%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a hematology & oncology specialist in Fresno?
Compare hematology & oncology specialists in the Fresno area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
28
Per 100K population
2.8
County median income
$71,434
Nearest hospital
COMMUNITY REGIONAL MEDICAL CENTER
1.2 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Saeed Tehrani is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Saeed Tehrani experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Saeed Tehrani performed 620 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Saeed Tehrani receive payments from pharmaceutical companies?
Yes. Dr. Saeed Tehrani received a total of $8,574 from 54 companies across 239 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Saeed Tehrani's costs compare to other hematology & oncology specialists in Fresno?
Dr. Saeed Tehrani's average Medicare payment per service is $131. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Saeed Tehrani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →